| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lipocine Inc. (LPCN) has 3 insiders with recent SEC Form 4 filings, including 4 buys and 1 sell. LPCN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 203.8K | $472.8K | - | |
| CEO | 160.7K | $372.8K | - | |
| Other | 40.1K | $93.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2017 | Hill Stephen A | Director | Sale+OE | 1,250 | $3.47 | $4,341.50 | -19.2% | |
| Sep 30, 2015 | Patel Mahesh V. | President And CEO | Buy | 4,000 | $11.84 | $47,354.73 | +0.2% | |
| Sep 30, 2015 | Higuchi John W. | Director | Buy | 5,000 | $12.68 | $63,400.00 | +0.7% |